Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis
Figure 1
MAT reduces clinical signs of EAE. (a) Structure of MAT. (b) Effect-versus-time curves of MAT effects on EAE. Clinical EAE was scored daily after immunization according to a 0–5 scale. (c) The mean maximum clinical scores are expressed as mean ± SD ( each group). , compared to naive group; , compared to vehicle-treated group.